Email this article to a friend
Impact of concomitant DMARD therapy on adherence to treatment with etanercept and infliximab in rheumatoid arthritis. Results from a six-year observational study in southern Sweden
-
* Corresponding author: Lars E Kristensen LarsErik.Kristensen@skane.se
Arthritis Research & Therapy 2006, 8:R174 doi:10.1186/ar2084